Matches in SemOpenAlex for { <https://semopenalex.org/work/W2811422218> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- W2811422218 endingPage "S167" @default.
- W2811422218 startingPage "S167" @default.
- W2811422218 abstract "The objective of this study was to conduct the first Cost Benefit (CBA) and Cost Effectiveness (CEA) analysis of Ultra-Violet Germicidal Irradiation (UVGI) technology in a Canadian health region. UVGI uses ultra violet light to irradiate environments in a biocidal manner to eliminate pathogens including Clostridium difficile (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA). A multi-year trial implemented UVGI technology across three hospital sites within a Canadian health region in 2016-2017. Rates of CDI and MRSA were observed and compared in the trial year and prior year across trial and non-trial sites. Change in trial sites' rates were adjusted for patient days across years, and for the change in rate in non-trial sites. A CBA was then conducted using cost savings calculated from the adjusted decrease in rates. A CEA was also conducted based on the expenditure required for the UVGI technology, and patient days avoided as well as CDI and MRSA cases avoided. Sensitivity analysis was conducted to account for differences in avoided CDI cost estimates, and purchasing vs. leasing costs of UVGI tech. The CBA determined that over the 6 month trial period, the UVGI technology delivered between $165,194 and $415,905 in benefit based on the costs avoided through CDI and MRSA cases avoided. The CEA determined that $620 could be spent on the UVGI technology to avoid one bed day, $10,171 could be spent to avoid one case of CDI, and $29,301 could be spent to avoid one case of MRSA (assuming the technology was purchased). The results of the analyses suggest that the UVGI technology delivers value for money. However, there are several limitations to this research including potential regression to the mean bias. Additional research is recommended using pre and post implementation data." @default.
- W2811422218 created "2018-07-10" @default.
- W2811422218 creator A5006174923 @default.
- W2811422218 date "2018-05-01" @default.
- W2811422218 modified "2023-09-26" @default.
- W2811422218 title "Cost Effectiveness of Ultra-Violet Germicidal Irradiation in Canadian Health Region" @default.
- W2811422218 doi "https://doi.org/10.1016/j.jval.2018.04.1127" @default.
- W2811422218 hasPublicationYear "2018" @default.
- W2811422218 type Work @default.
- W2811422218 sameAs 2811422218 @default.
- W2811422218 citedByCount "0" @default.
- W2811422218 crossrefType "journal-article" @default.
- W2811422218 hasAuthorship W2811422218A5006174923 @default.
- W2811422218 hasBestOaLocation W28114222181 @default.
- W2811422218 hasConcept C194828623 @default.
- W2811422218 hasConcept C71924100 @default.
- W2811422218 hasConceptScore W2811422218C194828623 @default.
- W2811422218 hasConceptScore W2811422218C71924100 @default.
- W2811422218 hasLocation W28114222181 @default.
- W2811422218 hasOpenAccess W2811422218 @default.
- W2811422218 hasPrimaryLocation W28114222181 @default.
- W2811422218 hasRelatedWork W159247329 @default.
- W2811422218 hasRelatedWork W2025193597 @default.
- W2811422218 hasRelatedWork W2042489430 @default.
- W2811422218 hasRelatedWork W2083479052 @default.
- W2811422218 hasRelatedWork W2115778339 @default.
- W2811422218 hasRelatedWork W2510700473 @default.
- W2811422218 hasRelatedWork W2531873760 @default.
- W2811422218 hasRelatedWork W2626766173 @default.
- W2811422218 hasRelatedWork W3154944956 @default.
- W2811422218 hasRelatedWork W4232888950 @default.
- W2811422218 hasVolume "21" @default.
- W2811422218 isParatext "false" @default.
- W2811422218 isRetracted "false" @default.
- W2811422218 magId "2811422218" @default.
- W2811422218 workType "article" @default.